EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Expressing miR-282 mitigates Aβ42-induced neurodegeneration in Alzheimer's model in Drosophila

Yu-Hsuan Huang, Hui-Wen Shih, Yu-Chen Tsai

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Yu-Hsuan Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science and Life Science Center, Tunghai University, Taichung, 40704, Taiwan R.O.C. Hauptthemen laut MEDLINE: MicroRNAs, Alzheimer Disease, Amyloid beta-Peptides, Disease Models, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease is a complex neurodegenerative condition characterized by the accumulation of amyloid beta plaques, leading to memory loss, cognitive decline, and impaired autonomous behavior. Despite extensive research, an effective treatment remains elusive. The buildup of amyloid beta plaques (Aβ42) in the brain causes oxidative stress and disrupts normal molecular signaling, adversely affecting neuron function. Previous research has identified factors that can either exacerbate or mitigate neurodegenerative diseases. Our study aimed to uncover new factors involved in the pathogenesis of Alzheimer's disease. Using Drosophila as a model organism, we employed the Gal4/UAS system to express human Aβ42 in the flies' retinal neurons which led to neurodegenerative changes in their compound eyes. To identify genetic modifiers, we conducted a screen by co-expressing microRNAs and found that miR-282 acts as a suppressor. Overexpressing miR-282 in the GMR > Aβ42 background reduced Aβ42-induced neurodegeneration. Further analysis using prediction tools and RNA interference experiments identified three potential downstream targets of miR-282: calpain-B, knot, and scabrous. Downregulating these genes via RNA interference in the GMR > Aβ42 background mitigated neurodegeneration. Our research highlights miR-282 as a novel molecule that may influence the progression of Alzheimer's disease, offering potential avenues for future therapeutic or diagnostic developments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsAlzheimer DiseaseAmyloid beta-PeptidesDisease Models, AnimalPeptide FragmentsAnimalsHumansDrosophila ProteinsDrosophila melanogasterCalpainDrosophilaAnimals, Genetically ModifiedNerve Degeneration

Stichwörter der Autor:innen

Alzheimer's modelAmyloid beta 42DrosophilaNeurodegenerationmiR-282

Substanzen

MicroRNAsAmyloid beta-Peptidesamyloid beta-protein (1-42)Peptide FragmentsDrosophila ProteinsCalpain

Autor:innen und Institutionen

  • Department of Life Science and Life Science Center, Tunghai University, Taichung, 40704, Taiwan R.O.C.
  • Department of Life Science and Life Science Center, Tunghai University, Taichung, 40704, Taiwan R.O.C. Electronic address: yctsaibio@thu.edu.tw.

Förderung

  • National Science and Technology Council

Zitieren

APA

Huang, Y. H., Shih, H. W., & Tsai, Y. C. (2024). Expressing miR-282 mitigates Aβ42-induced neurodegeneration in Alzheimer's model in Drosophila. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150768

Vancouver

Huang YH, Shih HW, Tsai YC. Expressing miR-282 mitigates Aβ42-induced neurodegeneration in Alzheimer's model in Drosophila. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150768

BibTeX
@article{Huang2024,
  author = {Huang, Yu-Hsuan and Shih, Hui-Wen and Tsai, Yu-Chen},
  title = {Expressing miR-282 mitigates Aβ42-induced neurodegeneration in Alzheimer's model in Drosophila},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150768}
}
Kostenlos starten →